Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NYC Pain Management Doctors Introduce DISCSEEL® Procedure for Chronic Disc-Related Back Pain


News provided by

Pain Management NYC

Feb 02, 2026, 09:58 ET

Share this article

Share toX

Share this article

Share toX


Respected New York pain physicians Dr. Dmitriy Dvoskin and Dr. Boleslav Kosharskyy now offer the revolutionary DISCSEEL® Procedure, an FDA-approved, minimally invasive treatment designed to address chronic disc-related back pain without traditional spine surgery.

NEW YORK, Feb. 2, 2026 /PRNewswire-PRWeb/ -- Patients suffering from chronic back pain caused by conditions such as degenerative disc disease, herniated discs, or sciatica may now have a minimally invasive alternative to traditional spine surgery. Pain Management NYC announced that interventional pain specialists Dr. Dmitriy Dvoskin, MD, and Dr. Boleslav Kosharskyy, MD, have completed advanced training to offer the DISCSEEL® Procedure, a non-surgical treatment designed to identify and seal painful spinal disc tears.

Degenerative disc disease is a common cause of chronic back pain and can progressively limit mobility and quality of life, according to Duke Health, one of the nation's leading academic medical centers. Many patients with disc-related pain do not achieve adequate relief from physical therapy, medications, or injections and may be hesitant to pursue invasive spine surgery.

"The DISCSEEL® Procedure meets our rigorous criteria for safety and efficacy. By utilizing this advanced biologic approach, we can provide long-term relief for patients struggling with chronic disc-related pain—even those for whom traditional treatments have previously failed," says Dr. Kosharskyy.

Post this

The DISCSEEL® Advantage

The DISCSEEL® Procedure is an outpatient, image-guided treatment that focuses on addressing the underlying source of disc-related pain. The procedure is FDA-cleared and may only be performed by physicians who are licensed and trained by DISCSEEL® Technologies.

Clinical research published in the peer-reviewed journal Pain Physician reports that approximately 50 percent of study participants experienced sustained pain relief at one year, with continued improvement observed in some patients for up to three years following treatment. No significant adverse events were reported in the study.

"We're excited to bring this advanced treatment option to patients who have struggled with chronic back pain and limited results from conservative care," said Dr. Dmitriy Dvoskin. "For some patients, DISCSEEL® may offer an alternative to long-term opioid use or invasive spine surgery."

The DISCSEEL® Procedure involves a two-step process. First, a contrast dye is injected into the spinal discs to precisely identify painful disc tears using advanced imaging. Once identified, the affected discs are treated during the same session with fibrin, a biologic material designed to help seal disc tears and support the body's natural healing response.

"This approach represents an important advancement in interventional and regenerative pain medicine," said Dr. Boleslav Kosharskyy. "By directly targeting disc pathology, we can help appropriately selected patients reduce pain and return to daily activities without the prolonged recovery associated with surgery."

Pain Management NYC is known for integrating evidence-based, minimally invasive treatments to address acute and chronic pain conditions, including spine, joint, and post-surgical pain. The practice serves patients throughout New York City and surrounding communities.

For more information on the DISCSEEL® Procedure or to arrange an interview, visit https://www.painmanagementnyc.com or call (212) 224-9555.

Learn more about the DISCSEEL® Procedure at https://discseel.com

About Dmitriy Dvoskin, MD

  • Dual Board Certified in Pain Medicine and Physical Medicine & Rehabilitation
  • Member, North American Spine Society
  • Member, International Spine Intervention Society
  • Member, American Medical Association

About Boleslav Kosharskyy, MD

  • Board Certified in Anesthesiology, Pain Medicine, and Palliative Care
  • Associate Professor of Anesthesiology and Rehabilitation Medicine, Albert Einstein College of Medicine
  • Associate Medical Director of Pain Medicine and Director of Anesthesia, Joint Replacement Center at Montefiore Medical Center
  • Diplomate, American Board of Anesthesiology
  • Fellow, Interventional Pain Practice
  • Member, American Society of Anesthesiologists

Media Contact

Dmitriy Dvoskin, MD

Pain Management NYC

Website: https://www.painmanagementnyc.com/

Phone: (212) 224-9555

Address: 240 E 23rd St., New York, NY 10010

Media Contact

Dmitriy Dvoskin, MD, Pain Management NYC, 1 (347) 458-2876, [email protected], https://www.painmanagementnyc.com/

SOURCE Pain Management NYC

Modal title

Patient Pre-DISCSEEL and 1 year after DISCSEEL procedure
Patient Pre-DISCSEEL and 1 year after DISCSEEL procedure
Dr. Leon Reyfman is explaining the DESCSEEL procedure to the patient.
Dr. Leon Reyfman is explaining the DESCSEEL procedure to the patient.
Patient Pre-DISCSEEL and 1 year after DISCSEEL procedure Dr. Leon Reyfman is explaining the DESCSEEL procedure to the patient.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.